MHC class II-peptide conjugates useful in ameliorating autoimmun

Drug – bio-affecting and body treating compositions – Free carbon containing

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530395, 530402, 530403, 530868, 514 2, 514 8, 4241841, 4241931, 4242781, A61K 39385, C07K 1474

Patent

active

054684811

ABSTRACT:
The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.

REFERENCES:
patent: 4199565 (1980-04-01), Fullerton
patent: 4400376 (1983-08-01), Sanderson
patent: 4478823 (1984-10-01), Sanderson
patent: 4675382 (1987-06-01), Murphy
patent: 4714759 (1987-12-01), Whitaker
patent: 4762915 (1988-08-01), King
patent: 5130297 (1992-07-01), Sharma et al.
patent: 5194425 (1993-03-01), Sharma et al.
patent: 5223241 (1993-06-01), Isobe et al.
patent: 5260422 (1993-11-01), Clark et al.
patent: 5284935 (1994-02-01), Clark et al.
W. F. Paul (ed), Fundamental Immunology, 3rd edition (1993) pp. 619-621.
Bell, J. I. et al., CSH Sympos. Quant. Biol. 51:75-82 (1986), "Molecular biology of the class II region of the human major histocompatibility complex."
Foulis, A. K., J. Pathol. 150:5-11 (1986) "Class II major histocompatibility complex and organ specific autoimmunity in man".
Sharma, S., et al. PNAS 88:11465-11469 (1991), "Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes."
Viguer, M., et al., PNAS 87:7170-7174 (1990), "The invariant chain forms complexes with class II major histocompatibility complex molecules and antigenic peptides in vivo".
Babbitt, B. P. et al. (1985) Nature 317: 359-361.
Bjorkman, P. J. et al. (1987) Nature 329: 506-512.
Bjorkman, P. J. et al. (1987) Nature 329: 512-518.
Buus, S. et al. (1987) Science 235: 1353-1358.
Diener, E. et al. (1986) Science 231: 148-150.
Killen, J. A. et al. (1984) J. Immunol. 133: 2549-2553.
Livingstone, A. M. et al. (1987) Ann. Rev. Immunol. 5: 477-501.
Marx, J. L. (1987) Science 238: 613-614.
Paul, W. E. (1989) Fundamental Immunol. Raven Press, New York, pp. 69-73.
Puri, J. et al. (1980) Eur. J. Immunol. 10: 273-281.
Rennie, D. P. et al. (1983) The Lancet (Dec. 10) 1338-1340.
Sterz, R. K. M. et al. (1985) J. Immunol. 134: 841-846.
Townsend, A. et al. (1987) Nature 329: 482-483.
Turkewitz, A. P. et al. (1983) Molec. Immunol. 20: 1139-1147.
Unanue, E. R. et al. (1987) Science 236: 551-557.
Watts, T. H. et al. (1984) Proc. Natl. Acad. Sci. USA 81: 7564-7568.
Watts, T. H. et al. (1985) Proc. Natl. Acad. Sci. USA 82: 5480-5484.
Watts, T. H. et al. (1987) Ann. Rev. Immunol. 5: 461-475.
Clemetson, K. J. et al. (1986) In Membrane proteins: A Laboratory Manual, Ed. Azzi, A. et al., pp. 57-64.
Cooperman (1979) In Ribosomes Structure, Function, and Genetics. Ed. Chambliss et al. University Park Press, Baltimore Md. pp. 531-554.
Estess, P. et al. (1986) In Regulation of immune gene expression, Ed. Feldman, M. et al., Humana Press, p. 3-19.
Guillet et al. (1987) Science 235: 865-870.
Hall et al. (1985) Biochemistry 24: 5702-5711.
Harcourt, G. et al. (1987) Immunol. Today 8 (11): (news and features section).
Hixson, J. R. Medical Tribune (24 Jan. 1985) pp. 4-5.
Liu, M. A. et al. (1988) Science 239: 395-398.
Marrack, P. et al. (1988) Nature 332: 840-842.
Nakanishi, M. et al. (1983) Molec. Immunol. 20: 1227-1231.
Pastan, I. et al. (1986) Cell 47: 641-648.
Sekaly, R. P. et al. (1986) J. Exp. Med. 164: 1490-1504.
Shizuru, J. A. et al. (1988) Science 240: 659-662.
Springer, T. A. et al. (1976) Proc. Natl. Acad. Sci. USA 73: 2481-2485.
Sriram, S. et al. (1987) Concepts Immunopathol. 4: 275-286.
Vitetta, E. S. et al. (1987) Science 238: 1098-1104.
Watts, T. H. et al. (1988) In Processing and presentation of antigens, Academic Press, pp. 143-154.
Binz, H. et al. (1979) J. Exp. Med. 150: 1084-1097.
Gasciogne, N. R. J. et al. (1987) Proc. Natl. Acad. Sci. USA. 84: 2396-2340.
Margulies, D. H. et al. (1987) Immunol. Res. 6: 101-116.
McCluskey, J. et al. (1988) J. Immunol. 141: 1451-1455.
Lamb et al. (1987) EMBO J. 6: 1245-1249.
Berkower et al. (1986) J. Immunol. 136: 2498-2502.
Townsend et al. (1986) Cell 44: 959-968.
Sanderson et al. (1973) Transplantation 16: 304-312.
Turner et al. (1976) J. Biol. Chem. 250: 4512-4519.
Gorga et al. (1987) J. Biol. Chem. 262: 16087-16094.
Zamvil et al. (1985) J. Exp. Med. 162: 2107-2124.
Zamvil et al. (1985) Nature 317: 355-358.
Ceredig, R. et al. (1986) Eur. J. Immunol. 16: 30-34.
Essery, G. et al. (1988) Immunology 64: 413-417.
Jenkins, M. K. et al. (1987) J. Exp. Med. 165: 302-319.
Klein, J. (1984) Immunol. Reviews 81: 177-202.
Lamb, J. R. (1983) J. Exp. Med. 157: 1434-1447.
Lamb, J. R. (1984) Nature 308: 72-74.
Lamb, J. R. et al. (1986) Immunology 57: 331-335.
Lamb, J. R. et al. (1987) Eur. J. Immunol. 17: 1641-1644.
Larche, M. et al. (1988) Immunology 64: 101-105.
Madsen, J. C. et al. (1988) Nature 332: 161-164.
Miller, S. D. et al. (1979) J. Exp. Med. 149: 758-773.
Nau, G. J. et al. (1987) J. Immunol. 139: 114-122.
Quill, H. et al. (1987) J. Immunol. 138: 3704-3712.
Suzuki, G. et al. (1988) J. Immunol. 140: 1359-1365.
Zanders, E. D. et al. (1983) Nature 303: 625-627.
Zanders, E. D. et al. (1985) Eur. J. Immunol. 15: 302-305.
Germain, R. N. (1981) J. Immunol. 127:1964-1966.
Buss, S. et al. (1988) Science 242:1045-1047.
Nag, B. et al. (1992) J. of Immunol. 148(7):2040-2044.
Nag, B. et al. (1992) J. of Immunol. 148(2):369-372.
Nag, B. et al. (1991) J. of Immunological Methods 142:105-111.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

MHC class II-peptide conjugates useful in ameliorating autoimmun does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with MHC class II-peptide conjugates useful in ameliorating autoimmun, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MHC class II-peptide conjugates useful in ameliorating autoimmun will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1135247

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.